<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Sunburn</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Sunburn</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Sunburn</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Antony R Young, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Angela Tewari, MBBS, BSc, MRCP, PhD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Robert P Dellavalle, MD, PhD, MSPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel F Danzl, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Rosamaria Corona, MD, DSc</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 04, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H11503609"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Sunburn is an acute, transient, inflammatory response of the skin to excessive exposure to ultraviolet (UV) radiation from natural sunlight or artificial sources (eg, tanning beds, phototherapy devices)  (<a class="graphic graphic_picture graphicRef73224 graphicRef52112" href="/z/d/graphic/73224.html" rel="external">picture 1A-B</a>). Both ultraviolet B (UVB; 280 to 320 nm) and ultraviolet A (UVA; 320 to 400 nm) can cause sunburn, but the wavelengths that are the most effective at inducing erythema are in the UVB range [<a href="#rid1">1,2</a>].</p><p>Sunburn is a self-limited condition. The acute manifestations usually resolve in three to seven days. However, susceptibility to sunburn is a marker of genetic susceptibility to skin cancer and is associated with an increased risk of melanoma at all ages [<a href="#rid3">3,4</a>]. It is very important that clinicians counsel patients with increased susceptibility to sunburn about sun protection.</p><p>This topic will discuss the pathogenesis, clinical manifestations, and management of sunburn. Photosensitivity, photoprotection, and photosensitivity disorders are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6620.html" rel="external">"Overview of cutaneous photosensitivity: Photobiology, patient evaluation, and photoprotection"</a> and  <a class="medical medical_review" href="/z/d/html/13751.html" rel="external">"Selection of sunscreen and sun-protective measures"</a> and  <a class="medical medical_review" href="/z/d/html/6622.html" rel="external">"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment"</a>.)</p><p class="headingAnchor" id="H3400008"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Sunburn is common and occurs in individuals with all skin types. In the United States, the estimated sunburn prevalence (≥1 sunburn in the past 12 months) among all adults was approximately 34 percent in 2005, 37 percent in 2010, and 31 percent in 2015 [<a href="#rid5">5</a>]. Prevalences ranging from 20 to 70 percent have been reported in cross-sectional studies in Europe and Australia [<a href="#rid6">6-9</a>].</p><p>In the United States, the one-year prevalence of sunburn in African Americans and Hispanic Americans was 13 and 30 percent, respectively [<a href="#rid10">10</a>]. Higher rates of sunburn have been reported in Black people living in the United Kingdom and in Black Africans [<a href="#rid11">11</a>]. In fact, sunburn in Black skin is probably more common than realized. In a study on people of Black African or Black Caribbean heritage living in the United Kingdom, over 50 percent reported a lifetime history of sunburn [<a href="#rid12">12</a>].</p><p>Sunburn occurs more frequently among adolescents and young adults. In nation-wide surveys in the United States, approximately 70 percent of adolescents aged 11 to 18 years and 50 percent of adults aged 18 to 29 years reported at least one sunburn in the previous year [<a href="#rid13">13,14</a>].</p><p>The risk of sunburn is inversely related to latitude and is therefore greatest near the equator, where ultraviolet B (UVB) intensity is highest. The time of day is also important, and sunburn is more likely to occur at noon than earlier or later in the day. Cloud cover when the sun is high offers some protection, but significant quantities of ultraviolet (UV) radiation still reach the earth's surface [<a href="#rid15">15</a>]. Additional factors that increase the risk of sunburn include altitude (higher altitude and greater risk of sunburn as UV radiation intensity reaching the skin is greater) and reflection from snow (approximately 90 percent), sand (15 to 30 percent), and water (5 to 20 percent) [<a href="#rid16">16</a>]. There is also evidence that wet skin is more susceptible to erythema than dry skin [<a href="#rid17">17</a>].</p><p>Excessive consumption of alcohol may be a risk factor for sunburn [<a href="#rid18">18,19</a>]. In a study of beachgoers in Texas, participants reporting alcohol drinking on the beach had a greater body surface area with sunburn and blisters than nondrinkers [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H11503623"><span class="h1">PATHOGENESIS</span></p><p class="headingAnchor" id="H5000930"><span class="h2">Individual susceptibility</span><span class="headingEndMark"> — </span>The susceptibility to sunburn is highly variable among individuals. Phenotypic characteristics that confer high susceptibility to sunburn include fair skin, blue eyes, and red or blond hair [<a href="#rid21">21</a>]. An increased susceptibility to sunburn is also a marker of increased risk of melanoma and nonmelanoma skin cancer [<a href="#rid3">3,22,23</a>]. (See  <a class="medical medical_review" href="/z/d/html/4844.html" rel="external">"Melanoma: Epidemiology and risk factors", section on 'Ultraviolet radiation'</a> and  <a class="medical medical_review" href="/z/d/html/5335.html" rel="external">"Basal cell carcinoma: Epidemiology, pathogenesis, clinical features, and diagnosis", section on 'Ultraviolet radiation'</a>.)</p><p>An individual's susceptibility to sunburn can be assessed by determining the minimum erythema dose (MED), which is the lowest dose of ultraviolet (UV) radiation delivered to the skin that produces a clearly marginated erythema in the irradiated site 24 hours after a single exposure  (<a class="graphic graphic_picture graphicRef88081" href="/z/d/graphic/88081.html" rel="external">picture 1D</a>). The MED is considered the threshold for sunburn and is widely used as a dose unit in phototherapy, experimental photobiology, and for the determination of a sunscreen's sun protection factor. </p><p>In clinical practice, the self-reported tendency to develop sunburn or tanning after sun exposure is used to determine an individual's skin phototype  (<a class="graphic graphic_table graphicRef60541" href="/z/d/graphic/60541.html" rel="external">table 1</a>). Darker skin types (IV to VI) typically require higher doses of UV radiation to develop a visible erythema. On average, the MED of a skin type IV that tans well is about twice the MED of a skin type I that does not tan [<a href="#rid24">24</a>]. However, there is considerable overlap of MED values between different skin types. Individuals with skin types I and II may develop a sunburn with daily repeated suberythemal exposures (eg, 0.5 MED) [<a href="#rid25">25</a>]. </p><p class="headingAnchor" id="H5002232"><span class="h2">Action spectra</span><span class="headingEndMark"> — </span>An action spectrum indicates which wavelengths most effectively produce a skin response and usually corresponds to the absorption spectrum for the chromophore (molecule that absorbs UV radiation photons) that initiates the response. The action spectrum for erythema indicates that the most effective wavelengths present in sunlight are in the ultraviolet B (UVB) range. Ultraviolet A (UVA) also can cause erythema, but doses nearly 1000 times higher than UVB are required [<a href="#rid1">1,2</a>].</p><p>The sun is primarily a UVA source, with UVB representing up to approximately 5 percent of the UV radiation reaching the earth's surface [<a href="#rid1">1</a>], although this contributes to over 80 percent of the erythemally effective energy [<a href="#rid26">26</a>]. Thus, the risk of sunburn is highest when the UVB to UVA ratio is high, as occurs between 11 AM and 3 PM in the summer months in temperate climates and particularly at latitudes approaching the equator [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H2456151"><span class="h2">Mechanism of ultraviolet B-induced inflammation</span><span class="headingEndMark"> — </span>In the sunburn response, many biochemical and cellular changes occur in the epidermis and dermis before the erythema becomes evident. However, the initiating events are incompletely understood, and the nature of the chromophore(s) (molecule absorbing the UV light) for erythema is still uncertain. The observation that the action spectrum for erythema is very similar to that for the induction of cyclobutane pyrimidine dimers (CPDs) suggests that DNA photodamage may be the trigger of the inflammatory cascade in sunburn [<a href="#rid1">1</a>]. UVB-mediated pigmentation (delayed tanning) can also be triggered by CPD, suggesting that inflammation and sunburn are also important in the tanning response [<a href="#rid28">28</a>].</p><p>Early events include vasodilation and increased blood flow, endothelial cell activation, formation of "sunburn cells" (ie, keratinocytes undergoing p53-dependent apoptosis), and release of inflammatory mediators [<a href="#rid29">29-33</a>]. Vasodilation of dermal small blood vessels and edema of endothelial cells occur within 30 minutes of sun exposure and peak at 24 hours [<a href="#rid34">34</a>]. Dyskeratotic "sunburn cells" may appear in the epidermis within hours of exposure [<a href="#rid35">35</a>].</p><p>Erythema becomes clinically apparent 3 to 6 hours after exposure, reaches a peak at 12 to 24 hours, and usually subsides at 72 hours. Neutrophilic infiltration starts approximately 3 hours after UVB exposure, peaks at 24 hours, and continues up to 48 hours later [<a href="#rid36">36-38</a>].</p><p>Prostaglandins and nitric oxide (NO) appear to be the major mediators of UVB-induced inflammation [<a href="#rid30">30,31</a>]. Numerous proinflammatory and anti-inflammatory eicosanoids have been identified in suction blister fluid over a 72-hour period after UVB exposure [<a href="#rid30">30</a>]. Vasodilatory prostaglandins (PG) PGE2, PGF2a, and PGE3 appear in the first 24 to 48 hours and are associated with increased COX-2 expression at 24 hours. Chemoattractant prostaglandins (11-, 12-, and 8-monohydroxy-eicosatetraenoic acid [HETE]) appear at 4 to 72 hours, whereas the anti-inflammatory 15-HETE is maximally present at 72 hours.</p><p>Several proinflammatory cytokines, including TNF-alpha, IL-1, IL-6, and IL-8, are elevated after UVB exposure. Cytokines may play several roles in UVB-induced inflammation, including activation of transcription factors, upregulation of endothelial adhesion molecules, and recruitment of neutrophils to the skin [<a href="#rid27">27</a>].</p><p class="headingAnchor" id="H16500253"><span class="h1">HISTOPATHOLOGY</span><span class="headingEndMark"> — </span>The extent and time course of the histological changes observed after ultraviolet B (UVB) exposure varies with the magnitude of the exposure dose. Epidermal changes include spongiosis, parakeratosis, and "sunburn cells" (apoptotic keratinocytes with condensed nuclear chromatin and eosinophilic cytoplasm). Sunburn cells may be present in the epidermis within hours of exposure and increase in number over the following 24 hours and form a band at the stratum corneum at 72 hours [<a href="#rid21">21</a>].</p><p>Dermal changes include endothelial cell swelling, perivenular edema, and presence of degranulated mast cells. A perivascular infiltrate of neutrophils appears shortly after the exposure and peaks at about 14 hours. A later mononuclear infiltrate persists for at least 48 hours.</p><p class="headingAnchor" id="H11503630"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Clinical manifestations of sunburn range from mild erythema to highly painful erythema with edema, vesiculation, and blistering  (<a class="graphic graphic_picture graphicRef73224 graphicRef59991 graphicRef52112 graphicRef88081" href="/z/d/graphic/73224.html" rel="external">picture 1A-D</a> and <a class="graphic graphic_table graphicRef61540" href="/z/d/graphic/61540.html" rel="external">table 2</a>). Blistering indicates superficial partial-thickness or, rarely, deep partial-thickness burn. (See  <a class="medical medical_review" href="/z/d/html/819.html" rel="external">"Assessment and classification of burn injury"</a>.)</p><p>Erythema is usually first noted 3 to 5 hours following sunlight exposure, peaks at 12 to 24 hours, and in most cases subsides at 72 hours [<a href="#rid27">27</a>]. The skin areas that were covered or shaded are typically spared  (<a class="graphic graphic_picture graphicRef52112" href="/z/d/graphic/52112.html" rel="external">picture 1B</a>). In individuals with highly pigmented skin, erythema may not be evident, and sunburn may manifest with skin peeling in the following days.</p><p>Increased skin sensitivity to heat and mechanical pressure are characteristic and present even in mild cases [<a href="#rid39">39</a>]. In severe cases, systemic symptoms, including headache, fever, nausea, and vomiting, may develop.</p><p class="headingAnchor" id="H1429517"><span class="h2">Clinical course</span><span class="headingEndMark"> — </span>The erythema typically resolves in three to seven days. Blisters heal without scarring in 7 to 10 days. Peeling of the skin, desquamation, and tanning are noted four to seven days after exposure.</p><p>In individuals with lightly pigmented skin, multiple permanent, brown macules, often with irregular borders, may occur after sunburn (sunburn-induced solar lentigines  (<a class="graphic graphic_picture graphicRef70005 graphicRef95126" href="/z/d/graphic/70005.html" rel="external">picture 2A-B</a>)). (See  <a class="medical medical_review" href="/z/d/html/5560.html" rel="external">"Benign pigmented skin lesions other than melanocytic nevi (moles)", section on 'Solar lentigo'</a>.)</p><p class="headingAnchor" id="H11503644"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of sunburn is usually straightforward, based upon the clinical findings of painful erythema with or without vesiculation and blistering  (<a class="graphic graphic_picture graphicRef73224 graphicRef88082 graphicRef59991 graphicRef52112" href="/z/d/graphic/73224.html" rel="external">picture 1A-C, 1E</a>) in exposed areas and a history of exposure to sunlight. Additional elements of history that may be helpful for the diagnosis include:</p><p class="bulletIndent1"><span class="glyph">●</span>Exposure to photosensitizing drugs  (<a class="graphic graphic_table graphicRef62152" href="/z/d/graphic/62152.html" rel="external">table 3</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Contact with topical photosensitizers  (<a class="graphic graphic_table graphicRef75581" href="/z/d/graphic/75581.html" rel="external">table 4</a>). Topical retinoids and alpha-hydroxy acids strip the top stratum corneum and can reduce the threshold for burning.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use of indoor tanning equipment.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Exposure to ultraviolet B (UVB) phototherapy or ultraviolet A (UVA) photochemotherapy (PUVA).</p><p></p><p class="headingAnchor" id="H57881440"><span class="h1">DIFFERENTIAL DIAGNOSIS</span></p><p class="headingAnchor" id="H11503651"><span class="h2">Exaggerated sunburn reactions</span><span class="headingEndMark"> — </span>Exaggerated sunburn reactions may occur as a result of exposure to phototoxic drugs or topical photosensitizer substances and in individuals with genetic disorders conferring an increased sensitivity to ultraviolet (UV) radiation:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Drug-induced phototoxic reactions </strong>– Phototoxic agents include drugs and other compounds that reduce the dose threshold for UV radiation-induced erythema when ingested or applied to the skin  (<a class="graphic graphic_table graphicRef62152" href="/z/d/graphic/62152.html" rel="external">table 3</a>). Phototoxic reactions appear as exaggerated sunburns, starting with a stinging or burning sensation associated with redness and swelling in exposed skin within minutes of sun exposure  (<a class="graphic graphic_picture graphicRef86479 graphicRef69140 graphicRef90426" href="/z/d/graphic/86479.html" rel="external">picture 3A-C</a>). (See  <a class="medical medical_review" href="/z/d/html/6622.html" rel="external">"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment", section on 'Phototoxicity'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Phytophotodermatitis</strong> – Phototoxic reactions may be induced by topical exposure to plants containing furocoumarins  (<a class="graphic graphic_table graphicRef75581" href="/z/d/graphic/75581.html" rel="external">table 4</a>). Patients with phytophotodermatitis typically present with erythema, edema, and bullae in linear or bizarre configurations that reflect the manner in which they have come in contact with the plant  (<a class="graphic graphic_picture graphicRef77829 graphicRef57871" href="/z/d/graphic/77829.html" rel="external">picture 4A-B</a>). (See  <a class="medical medical_review" href="/z/d/html/6622.html" rel="external">"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment", section on 'Phytophotodermatitis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Xeroderma pigmentosum</strong> – Xeroderma pigmentosum (XP) is an autosomal recessive disorder resulting from mutations in one of seven genes (XPA to XPG) involved in the nucleotide excision repair of UV radiation-induced photoproducts in DNA [<a href="#rid40">40,41</a>]. Infants with XP often experience severe sunburns after minimal sun exposure. Older children present with premature skin aging, pigmentary changes, and early development of skin cancers. (See  <a class="medical medical_review" href="/z/d/html/3004.html" rel="external">"The genodermatoses: An overview", section on 'Xeroderma pigmentosum'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Erythropoietic protoporphyria </strong>–<strong> </strong>Erythropoietic protoporphyria (EPP) is an inherited autosomal porphyria characterized by acute, painful, nonblistering photosensitivity episodes usually first noted in early childhood. The measurement of total and free erythrocyte protoporphyrin is necessary to confirm the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/7125.html" rel="external">"Erythropoietic protoporphyria and X-linked protoporphyria"</a>.)</p><p></p><p class="headingAnchor" id="H11503680"><span class="h2">Nonsunburn reactions</span><span class="headingEndMark"> — </span>Several idiopathic photodermatoses may mimic sunburn. However, they can be easily differentiated from sunburn based upon their clinical presentation and time course:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Polymorphous light eruption</strong> – Polymorphous light eruption (PLE) is an idiopathic photodermatosis characterized by erythematous, itchy papules and vesicles occurring hours to days after sun exposure and persisting for several days  (<a class="graphic graphic_picture graphicRef64270 graphicRef51455" href="/z/d/graphic/64270.html" rel="external">picture 5A-B</a>) [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/6623.html" rel="external">"Polymorphous light eruption"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Solar urticaria </strong>–<strong> </strong>Solar urticaria<strong> </strong>is a form of physical urticaria that presents with wheals or, less commonly, erythema alone after only minutes of exposure to sunlight and resolves within several hours  (<a class="graphic graphic_picture graphicRef57783" href="/z/d/graphic/57783.html" rel="external">picture 6</a>). Phototesting can confirm the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/8109.html" rel="external">"Physical (inducible) forms of urticaria", section on 'Solar urticaria'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Chronic actinic dermatitis</strong> – Chronic actinic dermatitis is a rare, persistent photo-induced eczema that typically affects men over 60 years  (<a class="graphic graphic_picture graphicRef101492 graphicRef101494" href="/z/d/graphic/101492.html" rel="external">picture 7A-B</a>). Many patients have a history of atopic dermatitis or a coexisting allergic contact dermatitis. (See  <a class="medical medical_review" href="/z/d/html/6622.html" rel="external">"Photosensitivity disorders (photodermatoses): Clinical manifestations, diagnosis, and treatment", section on 'Chronic actinic dermatitis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic lupus erythematosus</strong> — The classic butterfly rash of systemic lupus erythematosus  (<a class="graphic graphic_picture graphicRef75781 graphicRef55875" href="/z/d/graphic/75781.html" rel="external">picture 8A-B</a>), which usually appears after exposure to sunlight, is frequently mistaken for a sunburn. (See  <a class="medical medical_review" href="/z/d/html/4666.html" rel="external">"Overview of cutaneous lupus erythematosus", section on 'Acute cutaneous lupus erythematosus'</a>.)</p><p></p><p class="headingAnchor" id="H11503710"><span class="h1">MANAGEMENT</span></p><p class="headingAnchor" id="H641949453"><span class="h2">Mild to moderate sunburn</span><span class="headingEndMark"> — </span>Sunburn is a self-limiting condition that usually resolves in a few days. There are no specific therapies to reverse the skin damage and hasten the healing time. Management involves the symptomatic treatment of skin inflammation and control of pain:</p><p class="bulletIndent1"><span class="glyph">●</span>Cool compresses or soaks, <a class="drug drug_general" data-topicid="16451" href="/z/d/drug information/16451.html" rel="external">calamine lotion</a>, or aloe vera-based gels provide some relief of pain and discomfort. Bland emollients (eg, liquid paraffin/white soft paraffin 50/50) can be used on intact skin as tolerated. Ruptured blisters should be gently cleaned with mild soap and water and covered with wet dressings (eg, <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">saline</a> or petrolatum impregnated gauzes). Blisters should have the roof left on and the fluid inside extruded.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For the treatment of skin pain and inflammation, we suggest oral nonsteroidal anti-inflammatory drugs (NSAIDs). We generally use <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a> at a dose of 400 to 800 mg per dose three to four times per day in adults and children &gt;12 years and 4 to 10 mg/kg per dose every six to eight hours in children 6 months to 12 years. Treatment should be initiated as soon as the first symptoms become apparent and continued for 24 to 48 hours.</p><p></p><p class="bulletIndent1">The efficacy of oral NSAIDs for the symptomatic treatment of sunburn has not been adequately evaluated in randomized trials. In a few small observational studies of experimentally induced ultraviolet B (UVB) erythema, <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a>, <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a>, and <a class="drug drug_general" data-topicid="8559" href="/z/d/drug information/8559.html" rel="external">indomethacin</a> were reported as effective in reducing UVB-induced erythema if initiated before or immediately after the irradiation [<a href="#rid43">43-45</a>].</p><p></p><p class="bulletIndent1">In a double-blind crossover study, psoriatic patients receiving UVB phototherapy were given <a class="drug drug_general" data-topicid="8547" href="/z/d/drug information/8547.html" rel="external">ibuprofen</a> or placebo immediately after irradiation and for the following 24 hours [<a href="#rid46">46</a>]. Ibuprofen was more effective than placebo only in reducing technician-observed erythema, whereas no difference was noted for other endpoints (patient-observed erythema, pruritus, skin pain, general discomfort, and nocturnal restlessness).</p><p></p><p class="bulletIndent1">Topical <a class="drug drug_general" data-topicid="9348" href="/z/d/drug information/9348.html" rel="external">diclofenac</a> gel has been reported as effective in reducing pain and inflammation from sunburn [<a href="#rid47">47</a>]. However, topical diclofenac may induce allergic contact dermatitis and photoallergic contact dermatitis [<a href="#rid48">48-50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>We do <strong>not</strong> use topical corticosteroids for the treatment of sunburn. Although they are frequently used in clinical practice, there is little evidence that they are beneficial in reducing the symptoms and healing time of sunburn. </p><p></p><p class="bulletIndent1">In a study of patients with naturally acquired sunburn, participants reported similar pain, redness, and healing time for skin areas treated with topical <a class="drug drug_general" data-topicid="8458" href="/z/d/drug information/8458.html" rel="external">fluocinolone</a> acetonide or placebo [<a href="#rid51">51</a>]. In a randomized study of patients with experimentally induced UVB erythema, irradiated skin areas were treated with moderate- or high-potency topical corticosteroids  (<a class="graphic graphic_table graphicRef62402" href="/z/d/graphic/62402.html" rel="external">table 5</a>) 30 minutes before, 6 hours after, or 23 hours after exposure [<a href="#rid52">52</a>]. A clinically significant reduction of erythema was noted only in areas treated with high-potency corticosteroids before the irradiation.</p><p></p><p class="headingAnchor" id="H1429568"><span class="h2">Patients with severe sunburn</span><span class="headingEndMark"> — </span>Patients with extensive blistering sunburn, severe pain, and systemic symptoms (eg, fever, headache, vomiting, dehydration) may require hospitalization for fluid replacement and parenteral analgesia  (<a class="graphic graphic_table graphicRef74855" href="/z/d/graphic/74855.html" rel="external">table 6</a>). (See  <a class="medical medical_review" href="/z/d/html/114176.html" rel="external">"Treatment of superficial burns requiring hospital admission", section on 'Assessment for inpatient care'</a>.)</p><p>Blistered areas should be gently cleaned with mild soap and water and covered with sterile dressings. Topical antimicrobials or antibiotics (eg, <a class="drug drug_general" data-topicid="9890" href="/z/d/drug information/9890.html" rel="external">silver sulfadiazine</a> or <a class="drug drug_general" data-topicid="9668" href="/z/d/drug information/9668.html" rel="external">mupirocin</a> 2% ointment) may be used to prevent bacterial superinfection. (See  <a class="medical medical_review" href="/z/d/html/114176.html" rel="external">"Treatment of superficial burns requiring hospital admission", section on 'Burn wound dressings and topical therapy'</a> and  <a class="medical medical_review" href="/z/d/html/13509.html" rel="external">"Topical agents and dressings for local burn wound care"</a>.)</p><p>There is no evidence that oral corticosteroids are useful in severe sunburn. In a small study, participants received <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">prednisone</a> 80 mg or placebo immediately after UVB irradiation and for the following three days [<a href="#rid53">53</a>]. Prednisone was not more effective than placebo in reducing erythema, edema, and pain of the irradiated sites.</p><p class="headingAnchor" id="H11503768"><span class="h1">PREVENTION</span><span class="headingEndMark"> — </span>Prevention of sunburn involves sun avoidance, wearing protective clothing, and liberal use of broad spectrum sunscreens. It is important that clinicians counsel patients with sun-sensitive skin types about sun protection, because susceptibility to sunburn is a marker of genetic susceptibility to skin cancer and is associated with an increased risk of melanoma at all ages [<a href="#rid3">3,4</a>]. Patients using regular sunscreen experience less sunburn than those who occasionally use it, although this effect may be in part due to safer sun behavior among regular sunscreen users [<a href="#rid54">54,55</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Seeking shade</strong> – Individuals should be advised to seek shade or reduce exposure particularly in the summer months and between 10:00 AM and 4:00 PM, when sunlight intensity is greatest. Infants younger than six months should be kept out of direct sunlight.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Wear protective clothing</strong> – Protective clothing such as long sleeves and broad brim hats should be worn while outdoors. Fabrics that are tightly woven, thick, or dark colored are useful for protection. Clothing developed for photosensitive individuals is commercially available from specialty companies. (See  <a class="medical medical_review" href="/z/d/html/13751.html" rel="external">"Selection of sunscreen and sun-protective measures", section on 'Photoprotective clothing'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Use broad spectrum sunscreen</strong> – Broad spectrum sunscreens with sun protection factor (SPF) 30 or higher should be regularly used when performing outdoor activities in sunny weather, especially in regions with high levels of insolation. Sunscreens should be applied 15 to 30 minutes before sun exposure to allow the formation of a protective film on the skin and reapplied at least every two hours. (See  <a class="medical medical_review" href="/z/d/html/13751.html" rel="external">"Selection of sunscreen and sun-protective measures"</a> and  <a class="medical medical_review" href="/z/d/html/13751.html" rel="external">"Selection of sunscreen and sun-protective measures", section on 'Proper use of sunscreens'</a>.)</p><p></p><p class="bulletIndent1">For infants younger than six months, the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.healthychildren.org%2FEnglish%2Fsafety-prevention%2Fat-play%2FPages%2FSun-Safety.aspx&amp;token=KAnV8CtbiA6dlyC1XYJXhPC05TXx7YASg1mDIlLJU81yWPiRk%2BQ5nRf6%2BzqSCHk4G7xvtQ3SA%2FA49QvPG0c6zwHeGXub4znefjSuBC2Jmd%2F%2FUewJaYgRQGNsPbprcGQ6&amp;TOPIC_ID=6624" target="_blank">American Academy of Pediatrics</a> recommends using a minimal amount of sunscreen with an SPF of ≥15 on small areas (eg, face, back of hands) when adequate clothing and shade are not available.</p><p></p><p>Intentional tanning by using ultraviolet A (UVA) tanning beds does <strong>not </strong>protect against the risk of sunburn. Although suberythemal repetitive exposures to UVA induce a visible increase in skin pigmentation (immediate tanning, due to oxidation and redistribution of existing melanin), they do not increase melanin production and provide little or no photoprotection against subsequent UV exposures [<a href="#rid56">56</a>].</p><p class="headingAnchor" id="H3025045815"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/117752.html" rel="external">"Society guideline links: Care of the patient with burn injury"</a>.)</p><p class="headingAnchor" id="H641949500"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15739.html" rel="external">"Patient education: Sunburn (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/2730.html" rel="external">"Patient education: Sunburn (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H1429681"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – Sunburn is an acute, delayed, and transient inflammatory response of the skin to excessive exposure to ultraviolet (UV) radiation from natural sunlight or artificial sources. Both ultraviolet B (UVB) and ultraviolet A (UVA) can cause sunburn; however, the wavelengths that are most effective in inducing erythema are in the UVB range (290 to 320 nm). (See <a class="local">'Introduction'</a> above and <a class="local">'Action spectra'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Clinical manifestations of sunburn include painful erythema with or without edema, vesiculation, and blistering  (<a class="graphic graphic_picture graphicRef73224 graphicRef59991 graphicRef52112 graphicRef88081" href="/z/d/graphic/73224.html" rel="external">picture 1A-D</a> and <a class="graphic graphic_table graphicRef61540" href="/z/d/graphic/61540.html" rel="external">table 2</a>). Erythema is usually first noted 3 to 5 hours following sunlight exposure, peaks at 12 to 24 hours, and usually subsides at 72 hours. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of sunburn is usually straightforward, based upon the clinical findings  (<a class="graphic graphic_picture graphicRef73224 graphicRef88082 graphicRef59991 graphicRef52112" href="/z/d/graphic/73224.html" rel="external">picture 1A-C, 1E</a>) and a history of exposure to sunlight or artificial sources of UV radiation. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> – Sunburn is a self-limiting condition that in most cases resolves in a few days. There are no specific therapies to reverse the skin damage and hasten the healing time:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Mild to moderate sunburn</strong> – Cool compresses or soaks, <a class="drug drug_general" data-topicid="16451" href="/z/d/drug information/16451.html" rel="external">calamine lotion</a>, or aloe vera-based gels may be used for the relief of skin discomfort. For the treatment of skin pain and inflammation, we suggest oral nonsteroidal anti-inflammatory drugs (NSAIDs) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Severe sunburn</strong> – Patients with extensive blistering sunburn, severe pain, and systemic symptoms may require hospitalization for fluid replacement and parenteral analgesia  (<a class="graphic graphic_table graphicRef74855" href="/z/d/graphic/74855.html" rel="external">table 6</a>). Wound care is similar as for superficial burns. (See <a class="local">'Patients with severe sunburn'</a> above and  <a class="medical medical_review" href="/z/d/html/114176.html" rel="external">"Treatment of superficial burns requiring hospital admission"</a>.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Young AR. Acute effects of UVR on human eyes and skin. Prog Biophys Mol Biol 2006; 92:80.</a></li><li><a class="nounderline abstract_t">Young AR, Chadwick CA, Harrison GI, et al. The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema. J Invest Dermatol 1998; 111:982.</a></li><li><a class="nounderline abstract_t">Chang YM, Barrett JH, Bishop DT, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 2009; 38:814.</a></li><li><a class="nounderline abstract_t">Dennis LK, Vanbeek MJ, Beane Freeman LE, et al. Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis. Ann Epidemiol 2008; 18:614.</a></li><li><a class="nounderline abstract_t">Holman DM, Ding H, Berkowitz Z, et al. Sunburn prevalence among US adults, National Health Interview Survey 2005, 2010, and 2015. J Am Acad Dermatol 2019; 80:817.</a></li><li><a class="nounderline abstract_t">Horsley L, Charlton A, Waterman C. Current action for skin cancer risk reduction in English schools: pupils' behaviour in relation to sunburn. Health Educ Res 2002; 17:715.</a></li><li><a class="nounderline abstract_t">Køster B, Thorgaard C, Philip A, Clemmensen IH. Prevalence of sunburn and sun-related behaviour in the Danish population: a cross-sectional study. Scand J Public Health 2010; 38:548.</a></li><li><a class="nounderline abstract_t">Bränström R, Kristjansson S, Dal H, Rodvall Y. Sun exposure and sunburn among Swedish toddlers. Eur J Cancer 2006; 42:1441.</a></li><li><a class="nounderline abstract_t">Rogers C, Kvaskoff M, DiSipio T, et al. Prevalence and determinants of sunburn in Queensland. Health Promot J Austr 2009; 20:102.</a></li><li><a class="nounderline abstract_t">Holman DM, Ding H, Guy GP Jr, et al. Prevalence of Sun Protection Use and Sunburn and Association of Demographic and Behaviorial Characteristics With Sunburn Among US Adults. JAMA Dermatol 2018; 154:561.</a></li><li><a class="nounderline abstract_t">Diffey BL, Fajuyigbe D, Wright CY. Sunburn and sun protection in black skin. Int J Dermatol 2019; 58:1053.</a></li><li><a class="nounderline abstract_t">Bello O, Sudhoff H, Goon P. Sunburn Prevalence is Underestimated in UK-Based People of African Ancestry. Clin Cosmet Investig Dermatol 2021; 14:1791.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Sunburn and sun protective behaviors among adults aged 18-29 years--United States, 2000-2010. MMWR Morb Mortal Wkly Rep 2012; 61:317.</a></li><li><a class="nounderline abstract_t">Cokkinides V, Weinstock M, Glanz K, et al. Trends in sunburns, sun protection practices, and attitudes toward sun exposure protection and tanning among US adolescents, 1998-2004. Pediatrics 2006; 118:853.</a></li><li><a class="nounderline abstract_t">Diffey BL. What is light? Photodermatol Photoimmunol Photomed 2002; 18:68.</a></li><li><a class="nounderline abstract_t">Diffey BL. Sources and measurement of ultraviolet radiation. Methods 2002; 28:4.</a></li><li><a class="nounderline abstract_t">Moehrle M, Koehle W, Dietz K, Lischka G. Reduction of minimal erythema dose by sweating. Photodermatol Photoimmunol Photomed 2000; 16:260.</a></li><li><a class="nounderline abstract_t">Mukamal KJ. Alcohol consumption and self-reported sunburn: a cross-sectional, population-based survey. J Am Acad Dermatol 2006; 55:584.</a></li><li><a class="nounderline abstract_t">Duffy SA, Choi SH, Hollern R, Ronis DL. Factors associated with risky sun exposure behaviors among operating engineers. Am J Ind Med 2012; 55:786.</a></li><li><a class="nounderline abstract_t">Warthan MM, Sewell DS, Marlow RA, et al. The economic impact of acute sunburn. Arch Dermatol 2003; 139:1003.</a></li><li class="breakAll">Kochevar IE, Taylor CR, Krutmann J. Fundamentals of cutaneous photobiology and photoimmunology. In: Fitzpatrick's Dermatology in General Medicine, 8th Edition, Goldsmith LA, Katz SI, Gilchrest BA, et al (Eds), The McGraw-Hill Companies, 2012. Vol 1.</li><li><a class="nounderline abstract_t">Olsen CM, Zens MS, Green AC, et al. Biologic markers of sun exposure and melanoma risk in women: pooled case-control analysis. Int J Cancer 2011; 129:713.</a></li><li><a class="nounderline abstract_t">van Dam RM, Huang Z, Rimm EB, et al. Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study. Am J Epidemiol 1999; 150:459.</a></li><li><a class="nounderline abstract_t">Harrison GI, Young AR. Ultraviolet radiation-induced erythema in human skin. Methods 2002; 28:14.</a></li><li><a class="nounderline abstract_t">Young AR, Orchard GE, Harrison GI, Klock JL. The detrimental effects of daily sub-erythemal exposure on human skin in vivo can be prevented by a daily-care broad-spectrum sunscreen. J Invest Dermatol 2007; 127:975.</a></li><li><a class="nounderline abstract_t">Tewari A, Grage MM, Harrison GI, et al. UVA1 is skin deep: molecular and clinical implications. Photochem Photobiol Sci 2013; 12:95.</a></li><li class="breakAll">Rhodes LE, Lim HW. The acute effects of ultraviolet radiation on the skin. In: Photodermatology, Lim HW, Honigsmann H, Hawk JL (Eds), Informa Healthcare USA Inc, 2007. p.75.</li><li><a class="nounderline abstract_t">Fajuyigbe D, Young AR. The impact of skin colour on human photobiological responses. Pigment Cell Melanoma Res 2016; 29:607.</a></li><li><a class="nounderline abstract_t">Nicolaou A, Pilkington SM, Rhodes LE. Ultraviolet-radiation induced skin inflammation: dissecting the role of bioactive lipids. Chem Phys Lipids 2011; 164:535.</a></li><li><a class="nounderline abstract_t">Rhodes LE, Gledhill K, Masoodi M, et al. The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J 2009; 23:3947.</a></li><li><a class="nounderline abstract_t">Rhodes LE, Belgi G, Parslew R, et al. Ultraviolet-B-induced erythema is mediated by nitric oxide and prostaglandin E2 in combination. J Invest Dermatol 2001; 117:880.</a></li><li><a class="nounderline abstract_t">Nicolaou A, Masoodi M, Gledhill K, et al. The eicosanoid response to high dose UVR exposure of individuals prone and resistant to sunburn. Photochem Photobiol Sci 2012; 11:371.</a></li><li><a class="nounderline abstract_t">Murphy G, Young AR, Wulf HC, et al. The molecular determinants of sunburn cell formation. Exp Dermatol 2001; 10:155.</a></li><li><a class="nounderline abstract_t">Young AR, Guy RH, Maibach HI. Laser Doppler velocimetry to quantify UV-B induced increase in human skin blood flow. Photochem Photobiol 1985; 42:385.</a></li><li><a class="nounderline abstract_t">Gilchrest BA, Soter NA, Stoff JS, Mihm MC Jr. The human sunburn reaction: histologic and biochemical studies. J Am Acad Dermatol 1981; 5:411.</a></li><li><a class="nounderline abstract_t">Hawk JL, Murphy GM, Holden CA. The presence of neutrophils in human cutaneous ultraviolet-B inflammation. Br J Dermatol 1988; 118:27.</a></li><li><a class="nounderline abstract_t">Terui T, Takahashi K, Funayama M, et al. Occurrence of neutrophils and activated Th1 cells in UVB-induced erythema. Acta Derm Venereol 2001; 81:8.</a></li><li><a class="nounderline abstract_t">Terui T, Tagami H. Mediators of inflammation involved in UVB erythema. J Dermatol Sci 2000; 23 Suppl 1:S1.</a></li><li><a class="nounderline abstract_t">Harrison GI, Young AR, McMahon SB. Ultraviolet radiation-induced inflammation as a model for cutaneous hyperalgesia. J Invest Dermatol 2004; 122:183.</a></li><li><a class="nounderline abstract_t">Lehmann AR, McGibbon D, Stefanini M. Xeroderma pigmentosum. Orphanet J Rare Dis 2011; 6:70.</a></li><li><a class="nounderline abstract_t">DiGiovanna JJ, Kraemer KH. Shining a light on xeroderma pigmentosum. J Invest Dermatol 2012; 132:785.</a></li><li><a class="nounderline abstract_t">Pao C, Norris PG, Corbett M, Hawk JL. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994; 130:62.</a></li><li><a class="nounderline abstract_t">Edwards EK Jr, Horwitz SN, Frost P. Reduction of the erythema response to ultraviolet light by nonsteroidal antiinflammatory agents. Arch Dermatol Res 1982; 272:263.</a></li><li><a class="nounderline abstract_t">Gruber CM Jr, Ridolfo AS, Nickander R, Mikulaschek WM. Delay of erythema of human skin by anti-inflammatory drugs after ultraviolet irradiation. Clin Pharmacol Ther 1972; 13:109.</a></li><li><a class="nounderline abstract_t">Miller WS, Ruderman FR, Smith JG Jr. Aspirin and ultraviolet light-induced erythema in man. Arch Dermatol 1967; 95:357.</a></li><li><a class="nounderline abstract_t">Stern RS, Dodson TB. Ibuprofen in the treatment of UV-B-induced inflammation. Arch Dermatol 1985; 121:508.</a></li><li><a class="nounderline abstract_t">Kienzler JL, Magnette J, Queille-Roussel C, et al. Diclofenac-Na gel is effective in reducing the pain and inflammation associated with exposure to ultraviolet light - results of two clinical studies. Skin Pharmacol Physiol 2005; 18:144.</a></li><li><a class="nounderline abstract_t">Fernández-Jorge B, Goday-Buján JJ, Murga M, et al. Photoallergic contact dermatitis due to diclofenac with cross-reaction to aceclofenac: two case reports. Contact Dermatitis 2009; 61:236.</a></li><li><a class="nounderline abstract_t">Kowalzick L, Ziegler H. Photoallergic contact dermatitis from topical diclofenac in Solaraze gel. Contact Dermatitis 2006; 54:348.</a></li><li><a class="nounderline abstract_t">Lynde CB, Pierscianowski TA, Pratt MD. Allergic contact dermatitis caused by diclofenac cream. CMAJ 2009; 181:925.</a></li><li><a class="nounderline abstract_t">Russo PM, Schneiderman LJ. Effect of topical corticosteroids on symptoms of clinical sunburn. J Fam Pract 1978; 7:1129.</a></li><li><a class="nounderline abstract_t">Faurschou A, Wulf HC. Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial. Arch Dermatol 2008; 144:620.</a></li><li><a class="nounderline abstract_t">Greenwald JS, Parrish JA, Jaenicke KF, Anderson RR. Failure of systemically administered corticosteroids to suppress UVB-induced delayed erythema. J Am Acad Dermatol 1981; 5:197.</a></li><li><a class="nounderline abstract_t">Dusza SW, Halpern AC, Satagopan JM, et al. Prospective study of sunburn and sun behavior patterns during adolescence. Pediatrics 2012; 129:309.</a></li><li><a class="nounderline abstract_t">Ackermann S, Vuadens A, Levi F, Bulliard JL. Sun protective behaviour and sunburn prevalence in primary and secondary schoolchildren in western Switzerland. Swiss Med Wkly 2016; 146:w14370.</a></li><li><a class="nounderline abstract_t">Miyamura Y, Coelho SG, Schlenz K, et al. The deceptive nature of UVA tanning versus the modest protective effects of UVB tanning on human skin. Pigment Cell Melanoma Res 2011; 24:136.</a></li></ol></div><div id="topicVersionRevision">Topic 6624 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16600340" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Acute effects of UVR on human eyes and skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9856805" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19359257" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18652979" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Sunburns and risk of cutaneous melanoma: does age matter? A comprehensive meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30744879" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Sunburn prevalence among US adults, National Health Interview Survey 2005, 2010, and 2015.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12507347" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Current action for skin cancer risk reduction in English schools: pupils' behaviour in relation to sunburn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20484310" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Prevalence of sunburn and sun-related behaviour in the Danish population: a cross-sectional study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16737807" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Sun exposure and sunburn among Swedish toddlers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19642957" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Prevalence and determinants of sunburn in Queensland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29541756" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Prevalence of Sun Protection Use and Sunburn and Association of Demographic and Behaviorial Characteristics With Sunburn Among US Adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30710336" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Sunburn and sun protection in black skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34853522" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Sunburn Prevalence is Underestimated in UK-Based People of African Ancestry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22572977" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Sunburn and sun protective behaviors among adults aged 18-29 years--United States, 2000-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16950974" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Trends in sunburns, sun protection practices, and attitudes toward sun exposure protection and tanning among US adolescents, 1998-2004.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12147039" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : What is light?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12231182" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Sources and measurement of ultraviolet radiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11132129" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Reduction of minimal erythema dose by sweating.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17010736" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Alcohol consumption and self-reported sunburn: a cross-sectional, population-based survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22692974" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Factors associated with risky sun exposure behaviors among operating engineers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12925386" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : The economic impact of acute sunburn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12925386" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The economic impact of acute sunburn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20857492" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Biologic markers of sun exposure and melanoma risk in women: pooled case-control analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10472945" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Risk factors for basal cell carcinoma of the skin in men: results from the health professionals follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12231183" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Ultraviolet radiation-induced erythema in human skin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17082784" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The detrimental effects of daily sub-erythemal exposure on human skin in vivo can be prevented by a daily-care broad-spectrum sunscreen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23192740" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : UVA1 is skin deep: molecular and clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23192740" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : UVA1 is skin deep: molecular and clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27454804" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The impact of skin colour on human photobiological responses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21524643" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Ultraviolet-radiation induced skin inflammation: dissecting the role of bioactive lipids.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19584301" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11676827" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Ultraviolet-B-induced erythema is mediated by nitric oxide and prostaglandin E2 in combination.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22173231" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : The eicosanoid response to high dose UVR exposure of individuals prone and resistant to sunburn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11380610" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The molecular determinants of sunburn cell formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4089026" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Laser Doppler velocimetry to quantify UV-B induced increase in human skin blood flow.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7287956" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The human sunburn reaction: histologic and biochemical studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3342174" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : The presence of neutrophils in human cutaneous ultraviolet-B inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11411937" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Occurrence of neutrophils and activated Th1 cells in UVB-induced erythema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10764982" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Mediators of inflammation involved in UVB erythema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14962107" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Ultraviolet radiation-induced inflammation as a model for cutaneous hyperalgesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22044607" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Xeroderma pigmentosum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22217736" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Shining a light on xeroderma pigmentosum.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8305319" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Polymorphic light eruption: prevalence in Australia and England.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7165335" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Reduction of the erythema response to ultraviolet light by nonsteroidal antiinflammatory agents.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5008187" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Delay of erythema of human skin by anti-inflammatory drugs after ultraviolet irradiation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5336995" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Aspirin and ultraviolet light-induced erythema in man.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3883908" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Ibuprofen in the treatment of UV-B-induced inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15897687" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Diclofenac-Na gel is effective in reducing the pain and inflammation associated with exposure to ultraviolet light - results of two clinical studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19825096" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Photoallergic contact dermatitis due to diclofenac with cross-reaction to aceclofenac: two case reports.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16787462" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Photoallergic contact dermatitis from topical diclofenac in Solaraze gel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19858242" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Allergic contact dermatitis caused by diclofenac cream.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/748488" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Effect of topical corticosteroids on symptoms of clinical sunburn.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18490588" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Topical corticosteroids in the treatment of acute sunburn: a randomized, double-blind clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7021612" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Failure of systemically administered corticosteroids to suppress UVB-induced delayed erythema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22271688" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Prospective study of sunburn and sun behavior patterns during adolescence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27878788" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Sun protective behaviour and sunburn prevalence in primary and secondary schoolchildren in western Switzerland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20979596" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The deceptive nature of UVA tanning versus the modest protective effects of UVB tanning on human skin.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
